SEASON 1:

The Health Equalities Programme: COVID-19 SCIENCE Extended Dialogue took place between specialists in the field of MedTech to break down the barriers to vaccine uptake in the RBKC and to understand the thoughts and opinions of the Royal borough’s citizens. Many factors continue to promote vaccine hesitancy. Some of these factors include religious reasons, personal beliefs, safety concerns, and lack of information regarding vaccines, according to the Texas Tech University Health Sciences Center School of Pharmacy.

 

Skip to: 00:06 How MedTech came to the Royal Borough of Kensington & Chelsea. 

We explore this MedTech category in more detail, the reality of scientific developments and how this impacts the residents of the Royal Borough of Kensington & Chelsea. We also examine if Kensington is the next hub for tech start-ups, specifically those focusing on MedTech, due to contributions from  Imperial College London, Wearable Technologies division.

 

Skip to: 07:15 Biotechnology and the expansion of socialized medicine.

We also evaluate socialized medicine as a concept, vaccinations, their usage, importance, and access that are directly related to socialized medicine, a policy that has been adopted worldwide, during the Covid-19 pandemic. Though the United States is strongly focused on private healthcare setups, the system collapsed during the rise of Covid-19. On the other hand, the UK’s socialized medicine held up. Still, the backlog increased rapidly because of the enormous surge in cases.

 

Biotechnology is a vast field used in many different applications, including for the manufacturing of vaccines. Vaccines are biological preparations that require the use of biotechnological science and tools. Since the Covid-19 breakout, the medical segment of biotechnology has flourished considerably because of the increasing spread of the disease. Currently, the global net worth of the biotechnology market is around $793.87 billion, with the largest shareholder being North America.